Clinical Study of Risk Factors for Diabetic Maculopathy
PDF Downloads : 21    VIEW PDF

Keywords

Diabetic Maculopathy
Diabetic Macular edema
Diabetic retinopathy

How to Cite

Bangal, D. S. V., Patil, D. B. ., & Sharma, D. A. . (2021). Clinical Study of Risk Factors for Diabetic Maculopathy. VIMS Health Science Journal , 8(1), 9-13. https://doi.org/10.46858/vimshsj.8103

Abstract

Aim: To determine the association between various systemic risk factors with diabetic maculopathy. Methodology: A prospective observational study was conducted on 50 patients having diabetic maculopathy. Patients with maculopathies secondary to Vitreous Haemorrhage, Ocular disorders like Glaucoma, Uveitis, Advanced Diabetic Eye Disease, Vitreo-macular traction, maculopathy along with proliferative diabetic retinopathy, ischemic maculopathy, and history of laser treatment in last six months were excluded from the study. Data was collected using a structured proforma that included name, age, sex, occupation, height, weight, history of other systemic diseases like hypertension, investigations and treatment taken in past, family history, duration  of DM, smoking, hyperlipidemia, hyperglycemia and nephropathy. Results: Out of 50 patients, 38 (76%) were males and 12 (24%) were females suggestive of male predominance. Mean age of the patient was 57.36±11.65 years in males and 56.67±10.17 years in females. Among 50 patients, 19 patients had diabetes mellitus for 6-10 years duration, 14 patients had diabetes mellitus for 1-5 years, in 12 patients for 11-15 years, in 2 patients for 16-20 years, in 2 patients for 21-25 years and only 1 patient more than 25 years. Mean duration of DM was 12.2±6.1 years. Majority of patients having maculopathy had duration of DM up to 20 years. Among 50 patients, 27 patients (54%) had systemic hypertension, 37 patients (74%) had uncontrolled blood sugar level, 29 patients (58%) were found to have hyperlipidemia and 20 patients (40%) had nephropathy. Among 50 patients, pseudophakia was noted in 7 patients (14%), obesity was noted in 21patients (42%). Eleven patients (22%) were found to have anemia, 6 patients (12%) had family history of DM and 13 patients (26%) had history of smoking. Conclusion: Hyperglycemia, hypertension, duration of DM, hyperlipidemia are the major risk factors for the development and progression of diabetic maculopathy. While anemia, smoking, and obesity, family history of DM are the less significant risk factors.

https://doi.org/10.46858/vimshsj.8103
PDF Downloads : 21    VIEW PDF

References

Alvin C. Powers. Diabetes Mellitus. In Harrison’s Principles of Internal Medicine, Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo (eds), 17th edition, New York, McGraw-Hill Companies, 2008: 2275-85.

Kahn. HA, Moorhead. HB; Statistics on blindness in the Model Reporting Area 1969-70; Publication No. 72-472, Washington DC National Institute of Health, 1973.

International Diabetes Federation. IDF Diabetes Atlas, 6th edn. Brussels, Belgium: International Diabetes Federation, 2013.

Raman R, Rani PK, Rachepalle SR, Gnaanamurthy P, Uthra S, Govindasamy K, Sharma T. Prevalence of Diabetic Retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study Report 2. Ophthalmology 2009; 116(2): 311-318.

Joanne W.Y. Yau et al, Global Prevalence and Major Risk Factors of Diabetic Retinopathy, Diabetes Care March 2012 vol. 35 no. 3 556-564.

Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985; 103:1796–1806.

Muawyah D Al-Bdour, Maha I Al-Till, Khawla M Abu Samra. Risk factors for diabetic retinopathy among Jordanian diabetics. Middle East African Journal of Ophthalmology 2008; 15: 77-80.

Ahamadi MA, Lim JI. Update on laser treatment of diabetic macular edema. Int Ophthalmol Clin 2009; 49: 87-94.

Mc Donald RH, Schatz H. Grid Photocoagulation for diffuse macular edema. Retina 1985; 5: 65-72.

Lawson PM, Hunt B, Kohner EM. Medical Conditions in patients with diabetic maculopathy. Diabet Med 1985;2(4):245-50.

Sander B, Larsen M, Engler C, et al. Diabetic macular oedema: a comparison of vitreous fluorometry, angiography and retinopathy. Br J Ophthalmol 2002; 86:316-20.

Huirong Z, Xinrong L. Classification and visual prognosis of diabetic maculopathy. Chinese Journal of Ocular Fundus Diseases 2000-03.

Shetty KJ, Kalra D, Singha JN. Value of fluorescein angiography in the diagnosis of diabetic maculopathy. www.rssdi.org/1987-jan-april/proc10.pdf.

UK Prospective Diabetic Study Group: Tight blood pressure control and risk of macrovascular complications in type 2 diabetes (UKPD38). Br.Med J, 1998; 317:713-20.

Sjolie et al. Retinopathy and vision loss in insulin dependent diabetes in Europe. The EURODIAB IDDM Complications study. Ophthalmology, 1997; 104.252-60.

Muawyah D Al-Bdour, Maha I Al-Till, Khawla M Abu Samra. Risk factors for diabetic retinopathy among Jordanian diabetics. Middle East African Journal of Ophthalmology 2008; 15: 77-80.

Espiritu R, Grace SY. Fluorescein angiographically evident diabetic maculopathy. Clinical Haemorrheology and Microcirculation 2003; 29(3-4):357-65.

Jew OM, Peyman M, Chen TC, Visvaraja S. Risk factors for clinically significant macular edema in a multi-ethanics population with type 2 diabetes. Int J Ophthalmol.2012;5(4):499-504

The Diabetes Control and Complication Trial Research Group: The relation of glycemic exposure (Hb1AC) to the risk of development and progression of retinopathy in Diabetes Control and Complication Trial.: Diabetes. 1995; 44(8): 968.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2021 Dr. Surekha V. Bangal, Dr. Bhushan Patil, Dr. Akshita Sharma

Downloads

Download data is not yet available.